COSMOS Pharmaceutical Corporation (CSMYF)
USD 49.22
(0.0%)
USD 49.22
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 476.54 Billion JPY | 13.2% |
| 2023 | 420.96 Billion JPY | 15.95% |
| 2022 | 363.05 Billion JPY | 6.37% |
| 2021 | 341.31 Billion JPY | 6.57% |
| 2020 | 320.28 Billion JPY | 17.08% |
| 2019 | 273.56 Billion JPY | 9.16% |
| 2018 | 250.6 Billion JPY | 11.04% |
| 2017 | 225.69 Billion JPY | 11.4% |
| 2016 | 202.59 Billion JPY | 19.94% |
| 2015 | 168.91 Billion JPY | 18.37% |
| 2014 | 142.7 Billion JPY | 23.5% |
| 2013 | 115.54 Billion JPY | 16.16% |
| 2012 | 99.46 Billion JPY | 18.44% |
| 2011 | 83.98 Billion JPY | 14.13% |
| 2010 | 73.58 Billion JPY | 13.4% |
| 2009 | 64.89 Billion JPY | 20.11% |
| 2008 | 54.03 Billion JPY | 21.72% |
| 2007 | 44.38 Billion JPY | 16.62% |
| 2006 | 38.06 Billion JPY | 35.39% |
| 2005 | 28.11 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 430.24 Billion JPY | -1.36% |
| 2024 Q4 | 476.54 Billion JPY | 10.76% |
| 2024 FY | 476.54 Billion JPY | 13.2% |
| 2024 Q2 | 436.15 Billion JPY | 0.24% |
| 2024 Q1 | 435.12 Billion JPY | 3.36% |
| 2023 Q3 | 376.93 Billion JPY | -0.52% |
| 2023 FY | 420.96 Billion JPY | 15.95% |
| 2023 Q4 | 420.96 Billion JPY | 11.68% |
| 2023 Q2 | 378.88 Billion JPY | 1.5% |
| 2023 Q1 | 373.3 Billion JPY | 2.82% |
| 2022 Q4 | 363.05 Billion JPY | 5.71% |
| 2022 Q3 | 343.43 Billion JPY | -0.78% |
| 2022 FY | 363.05 Billion JPY | 6.37% |
| 2022 Q1 | 343.64 Billion JPY | 0.68% |
| 2022 Q2 | 346.13 Billion JPY | 0.73% |
| 2021 Q4 | 341.31 Billion JPY | 6.92% |
| 2021 Q1 | 315.35 Billion JPY | -1.54% |
| 2021 Q3 | 319.24 Billion JPY | 1.24% |
| 2021 Q2 | 315.32 Billion JPY | -0.01% |
| 2021 FY | 341.31 Billion JPY | 6.57% |
| 2020 Q4 | 320.28 Billion JPY | 13.64% |
| 2020 FY | 320.28 Billion JPY | 17.08% |
| 2020 Q1 | 273.73 Billion JPY | 0.06% |
| 2020 Q2 | 278.72 Billion JPY | 1.82% |
| 2020 Q3 | 281.83 Billion JPY | 1.11% |
| 2019 Q1 | 252.47 Billion JPY | 0.74% |
| 2019 Q4 | 273.56 Billion JPY | 5.03% |
| 2019 FY | 273.56 Billion JPY | 9.16% |
| 2019 Q2 | 255.03 Billion JPY | 1.02% |
| 2019 Q3 | 260.47 Billion JPY | 2.13% |
| 2018 FY | 250.6 Billion JPY | 11.04% |
| 2018 Q2 | 234.34 Billion JPY | 1.72% |
| 2018 Q1 | 230.38 Billion JPY | 2.08% |
| 2018 Q4 | 250.6 Billion JPY | 6.02% |
| 2018 Q3 | 236.37 Billion JPY | 0.86% |
| 2017 Q4 | 225.69 Billion JPY | 8.47% |
| 2017 FY | 225.69 Billion JPY | 11.4% |
| 2017 Q3 | 208.07 Billion JPY | -0.61% |
| 2017 Q2 | 209.34 Billion JPY | 1.87% |
| 2017 Q1 | 205.5 Billion JPY | 1.44% |
| 2016 Q1 | 172.18 Billion JPY | 1.93% |
| 2016 FY | 202.59 Billion JPY | 19.94% |
| 2016 Q4 | 202.59 Billion JPY | 7.63% |
| 2016 Q3 | 188.24 Billion JPY | -0.38% |
| 2016 Q2 | 188.96 Billion JPY | 9.75% |
| 2015 Q2 | 152.35 Billion JPY | -0.22% |
| 2015 Q3 | 162.47 Billion JPY | 6.64% |
| 2015 Q4 | 168.91 Billion JPY | 3.97% |
| 2015 FY | 168.91 Billion JPY | 18.37% |
| 2015 Q1 | 152.68 Billion JPY | 6.99% |
| 2014 Q2 | 125.14 Billion JPY | 6.36% |
| 2014 Q3 | 128.62 Billion JPY | 2.78% |
| 2014 FY | 142.7 Billion JPY | 23.5% |
| 2014 Q1 | 117.65 Billion JPY | 1.83% |
| 2014 Q4 | 142.7 Billion JPY | 10.94% |
| 2013 Q4 | 115.54 Billion JPY | 13.63% |
| 2013 Q2 | 108.4 Billion JPY | 6.72% |
| 2013 FY | 115.54 Billion JPY | 16.16% |
| 2013 Q1 | 101.57 Billion JPY | 2.12% |
| 2013 Q3 | 101.68 Billion JPY | -6.2% |
| 2012 FY | 99.46 Billion JPY | 18.44% |
| 2012 Q3 | 87.73 Billion JPY | -2.57% |
| 2012 Q2 | 90.04 Billion JPY | 4.66% |
| 2012 Q4 | 99.46 Billion JPY | 13.38% |
| 2012 Q1 | 86.03 Billion JPY | 2.44% |
| 2011 Q2 | 77.07 Billion JPY | 1.7% |
| 2011 FY | 83.98 Billion JPY | 14.13% |
| 2011 Q4 | 83.98 Billion JPY | 11.0% |
| 2011 Q3 | 75.66 Billion JPY | -1.83% |
| 2011 Q1 | 75.78 Billion JPY | 2.98% |
| 2010 Q3 | 66.81 Billion JPY | 0.0% |
| 2010 FY | 73.58 Billion JPY | 13.4% |
| 2010 Q4 | 73.58 Billion JPY | 10.14% |
| 2009 Q3 | 58.18 Billion JPY | 0.19% |
| 2009 FY | 64.89 Billion JPY | 20.11% |
| 2009 Q2 | 58.07 Billion JPY | 0.0% |
| 2009 Q4 | 64.89 Billion JPY | 11.52% |
| 2008 FY | 54.03 Billion JPY | 21.72% |
| 2007 FY | 44.38 Billion JPY | 16.62% |
| 2006 FY | 38.06 Billion JPY | 35.39% |
| 2005 FY | 28.11 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | 220.00 USD | -216611818081.818% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 567.74 Million USD | -83837.071% |
| Café Serendipity Holdings, Inc. | 1.04 Million USD | -45598722.678% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 501.27 Thousand USD | -95065921.118% |
| HealthWarehouse.com, Inc. | 3.2 Million USD | -14852482.479% |
| LIGAND PHARMACEUTICAL INC | 787.21 Million USD | -60435.609% |
| MedGen, Inc. | 0.79 USD | -60322278480912.658% |
| Omni Health, Inc. | 5.53 Million USD | -8614916.268% |
| Oxford Investments Holdings Inc. | 451.08 Thousand USD | -105645227.558% |
| Pineapple, Inc. | 7.83 Million USD | -6078576.632% |
| ScripsAmerica, Inc. | 5.64 Million USD | -8443255.074% |